EVIO (OTCQB: EVIO) this morning said in a news release that Felipe Campusano has joined the company’s board of directors as an independent director. “We are pleased to welcome Felipe to join our board and look forward to his contributions,” EVIO chief executive officer William Waldrop stated in the news release. “He’s been very successful operating Canadian pharmacies and his insight into the cannabis industry will be valuable to our business environment, including our new Bioscience division. Felipe’s expertise in pharmaceutical business management will strengthen EVIO’s ability to generate partnerships with medical and healthcare providers. He has disrupted the pharmaceutical industry with major expansions and with his guidance we look to rapidly grow our presence in Canada.”
To view the full press release, visit http://cnw.fm/M7thj
About EVIO, Inc.
EVIO Inc. is a leading provider of cannabis testing and scientific research for the regulated cannabis industry. The Company’s EVIO Labs division operates coast-to-coast, providing state-mandated ancillary services to ensure the safety and quality of the nation’s cannabis supply. EVIO is on track to have 18 of its state-of-the-art testing facilities by year-end 2018. For more information, visit the company’s website at www.EvioLabs.com.
More from CannabisNewsBreaks
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
For more information please visit https://www.cannabisnewswire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com